UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Aphiahsone-50mcg-Suspension-SE-IS-MPD-BBDL

Aphiahsone 50 mikrogram/dos Nässpray, suspension

MPID: SE-100002844-00051410
EURDID: 2085

Full name: Aphiahsone 50 mikrogram/dos Nässpray, suspension

- Invented name part: Aphiahsone

- Strength part: 50 mikrogram/dos

- Pharmaceutical dose form part: Nässpray, suspension

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Nasal spray, suspension

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000093533 R01AD09

Marketing Authorisation 1 of 1

Authorisation number: 51410

Region: Kingdom of Sweden

Marketing authorisation holder: Glenmark Arzneimittel GmbH

Identifier:

  • LOC-100014685

Status: Valid (2015-02-12)

Package 1 of 2

PCID:

Description:
Flaska med dospump, 140 doser

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Bottle

Package: 1 Box (Cardboard)

Containing:

Package: 1 Multidose container with pump (High Density PolyEthylene) (Aluminium)

Containing: 50 microgram(s)/dose

Manufactured Item

Dose form: Nasal spray, suspension

Unit of presentation: Bottle

Ingredient

Role: Active

Substance: Mometasone furoate monohydrate

Concentration strength: 51.73 microgram(s)/dose / 1 dose

Reference strength:
Mometasone furoate 50 microgram(s)/dose / 1 dose

Package 2 of 2

PCID:

Description:
Flaska med dospump, 3 x 140 doser

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 3 Bottle

Package: 1 Box (Cardboard)

Containing:

Package: 3 Multidose container with pump (High Density PolyEthylene) (Aluminium)

Containing: 50 microgram(s)/dose

Manufactured Item

Dose form: Nasal spray, suspension

Unit of presentation: Bottle

Ingredient

Role: Active

Substance: Mometasone furoate monohydrate

Concentration strength: 51.73 microgram(s)/dose / 1 dose

Reference strength:
Mometasone furoate 50 microgram(s)/dose / 1 dose

Administrable Product (1 of 1)

Dose form: Suspension for spray

Unit of presentation:

Route of administration:

  • Nasal use

Ingredients:

Ingredient

Role: Active

Substance: Mometasone furoate monohydrate

Concentration strength: 51.73 microgram(s)/dose / 1 dose

Reference strength:
Mometasone furoate 50 microgram(s)/dose / 1 dose